Back to Trials
NCT06744816EARLY_PHASE1Recruiting

Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study

M.D. Anderson Cancer Center

Start Date

12/11/2025

Completion Date

11/30/2027

Summary

To learn if topical capsaicin can help relieve pain from CIPN and improve gait (the pattern of walking) in patients.

Detailed Description

Primary Objectives • To assess changes in Gait (specifically looking at velocity) before and after use of topical capsaicin. Secondary Objectives * To assess Pain intensity numerical rating scale (NRS) scores in chemotherapy induced peripheral neuropathy (CIPN) participants before and after use of capsaicin 8% topical patch. * To assess changes in quantitative sensory testing (QST) before and after use of topical capsaicin. * To assess skin punch biopsy to compare the integrity of epidermal nerve fibers and Meissner's corpuscles (MC) in CIPN patients before and after use of topical capsaicin (optional). * To assess pain tumor related neuropathy assessment scale (TNAS) before and after topical capsaicin * To assess pain interference using the Brief Pain Inventory (BPI), before and after topical capsaicin * To assess Patient Global Impression of Change (PGIC) * To assess the rate of adverse events and tolerability of topical capsaicin as reported by participants

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Participants diagnosed with pain of the lower extremity from chronic (\>90 days duration) CIPN (due to either vinca alkaloids, taxanes, bortezomib, thalidomide, platinum-based compounds), seen at MD Anderson Cancer Center * Participants reporting baseline pain ≥ 4 (0-10 scale, NRS) * Participants age 18+ * Participants who have completed chemotherapy within the last year at the time of enrollment. Exclusion Criteria: * Participants with cognitive dysfunction * Participants with recent history (\<6 months) of drug or alcohol abuse * Participants with open skin lesion or undergoing antibiotic therapy for local for systemic infection * Participants with allergies to capsaicin or adhesives * Pregnant participants

Interventions

DRUG

Qutenza Patch

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Peripheral Neuropathy Due to Chemotherapy

Locations

MD Anderson Cancer Center

Houston, Texas 77030

United States